While using pharmacy-grade Tesamorelin and Ipamorelin, a user experienced significant numbness in their hand and fingers, particularly in the morning. The symptoms worsened after increasing the Ipamorelin dose and adding CJC-1295, but resolved within 24 hours of removing the CJC-1295 from the protocol.